Prosecution Insights
Prosecution Insights
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Universitätsklinikum Regensburg currently has 1 pending office action in its patent portfolio. This action is being reviewed by 1 distinct examiner within 1 distinct art unit. The absence of a specified technology area in the data suggests the portfolio may cover specialized or niche subject matter not categorized under the primary headings. This concentration of activity indicates a specific technical scope for their current intellectual property efforts at the USPTO.
ORWIG, KEVIN S is the busiest examiner for this institution, with 1 pending office action under review. Since the total count of 1 pending office action is concentrated here, this examiner is currently the sole point of contact for the company's active prosecution. The presence of 1 distinct art unit indicates that the current filing is being processed in a specific technical group. For Universitätsklinikum Regensburg, the prosecution path is currently singular and focused on the feedback from this 1 distinct examiner.
Practitioners should note that with only 1 distinct examiner involved, the company's immediate patent strategy is dependent on a single individual's review. This lack of diversification across multiple examiners or art units means that the outcome of the 1 pending office action will significantly impact the company's standing. The data reflects a portfolio that is not yet spread across different technical units, requiring a focused approach to the 1 busiest examiner pending case.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ORWIG, KEVIN S | 1 | 25.5% | +40.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18229565 | ANTI-HUMAN IL-3 ANTIBODIES, THEIR USE IN TREATMENT OF A DISEASE OR MALFUNCTION ASSOCIATED WITH ELEVATED EXPRESSION OR LEVELS OF IL-3, AND THEIR USE IN A METHOD TO DETECT HUMAN IL-3 | ORWIG, KEVIN S | 88d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18229565 | ANTI-HUMAN IL-3 ANTIBODIES, THEIR USE IN TREATMENT OF A DISEASE OR MALFUNCTION ASSOCIATED WITH ELEVATED EXPRESSION OR LEVELS OF IL-3, AND THEIR USE IN A METHOD TO DETECT HUMAN IL-3 | ORWIG, KEVIN S | 88d overdue |
| Art Unit | Apps |
|---|---|
| 3991 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18229565 | ANTI-HUMAN IL-3 ANTIBODIES, THEIR USE IN TREATMENT OF A DISEASE OR MALFUNCTION ASSOCIATED WITH ELEVATED EXPRESSION OR LEVELS OF IL-3, AND THEIR USE IN A METHOD TO DETECT HUMAN IL-3 | ORWIG, KEVIN S | 3991 | §112 | Final Rejection | 88d overdue | Pending | Aug 02, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial